Pharmacokinetic Analysis for the Differentiation of Pituitary Microadenoma Subtypes Through Dynamic Contrast‑enhanced Magnetic Resonance Imaging

Oncology Letters - Greece
doi 10.3892/ol.2019.10083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Pharmacokinetic Models in Prostate Cancer

European Radiology
MedicineNuclear MedicineRadiologyImaging
2010English

Contrast Agents in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Oncotarget
Oncology
2017English

Quantitative Analysis of Permeability for Glioma Grading Using Dynamic Contrast‑enhanced Magnetic Resonance Imaging

Oncology Letters
Cancer ResearchOncology
2017English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of OATP Dysfunction in Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Assessment of the Dynamic Range in Dynamic Contrast-Enhanced Magnetic Resonance Imaging Breast Examinations

Breast Cancer Research
Cancer ResearchOncology
2012English

The Use of Signal Phase in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

English

Imaging Tumor Vascular Heterogeneity and Angiogenesis Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Clinical Cancer Research
Cancer ResearchOncology
2007English

Techniques and Applications of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Cancer

2014English

Dynamic Contrast Enhanced Magnetic Resonance Imaging for Hypoxia Mapping and Potential for Brachytherapy Targeting

Physics and Imaging in Radiation Oncology
Nuclear MedicineRadiologyRadiationImagingOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy